hemarthrosis
hemarthrosis
Explore linked clinical trials. Standard reference: MONDO:00044315 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthropathy, blood coagulation disease, coagulation protein disease, hemarthrosis, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, musculoskeletal system disorder | Active, not recruiting | Not stated | 2026-09-25 | NCT06684314 | |
| ATHNdataset Registry | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Embolism and Thrombosis, Glanzmann thrombasthenia 1, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, X-linked disease, anemia, arthropathy, blood coagulation disease, blood platelet disease, cardiovascular disorder, coagulation protein disease, familial hemolytic anemia, hemarthrosis, hematologic disorder, hemolytic anemia, hemophilia A, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, inherited hemoglobinopathy, musculoskeletal system disorder, sickle cell disease, thrombotic disease, vascular disorder, vascular hemostatic disease, von Willebrand disease (hereditary or acquired) | Recruiting | Not stated | 2026-04-21 | NCT06820515 | |
| Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia A | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthropathy, blood coagulation disease, coagulation protein disease, hemarthrosis, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, musculoskeletal system disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-02-27 | NCT07439055 | |
| Study the Anti-inflammatory Effect of Tranexamic Acid When Used in Anterior Cruciate Ligament Reconstruction. | Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthropathy, hemarthrosis, musculoskeletal system disorder | Not yet recruiting | Phase 4 | 2026-01-12 | NCT07332910 | |
| Embolization in Hereditary Coagulopathies | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthropathy, blood coagulation disease, coagulation protein disease, hemarthrosis, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, musculoskeletal system disorder, synovitis | Recruiting | Not applicable | 2022-11-29 | NCT05629130 |